دورية أكاديمية
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors
| العنوان: | INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors |
|---|---|
| المؤلفون: | Hilton, John F., Ott, Patrick A., Hansen, Aaron R., Li, Zujun, Mathew, Matthen, Messina, Cristina H., Dave, Vimal, Ji, Xiao, Karpinich, Natalie O., Hirschfeld, Steven, Ballas, Marc, Zandberg, Dan P.Aff8, IDs0026202303623z_cor12 |
| المصدر: | Cancer Immunology, Immunotherapy. 73(3) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 14320851 |
|---|---|
| DOI: | 10.1007/s00262-023-03623-z |